Suscribirse

Defining diastolic dysfunction post-Fontan: Threshold, risk factors, and associations with outcomes - 27/08/25

Doi : 10.1016/j.ahj.2025.07.007 
Tarek Alsaied, MD, MSc a, , Runjia Li, MS b, Haley Grant, PhD b, Mary D. Schiff, PhD a, Yu Li, MD c, Adam B. Christopher, MD a, Jacqueline Kreutzer, MD a, Bryan H. Goldstein, MD a, Jonathan H. Soslow, MD d, Yue-Hin Loke, MD e, Mark A. Fogel, MD f, Timothy C. Slesnick, MD g, Rajesh Krishnamurthy, MD h, Vivek Muthurangu, MD, PhD i, Adam L. Dorfman, MD j, Christopher Lam, MD k, Justin D. Weigand, MD l, Joshua D. Robinson, MD m, Laura J. Olivieri, MD a, Rahul H. Rathod, MD, MBA n

the FORCE Investigators#

  The list of remaining FORCE investigators is provided in the supplement.
M Aggarwal 1, T Alsaied 2, AL Dorfman 3, A Doshi 4, MD Files 5, M Fogel 6, S Hegde 7, A Hoyer 8, T Johnson 9, R Krishnamurthy 10, CZ Lam 11, Y Loke 12, AL Marsden 13, V Muthurangu 14, LJ Olivieri 2, M Quail 14, F Raimondi 15, P Ramachandran 16, RH Rathod 17, P Renella 18, MS Renno 19, JD Robinson 20, G Ruchira 21, A Shah 22, TC Slesnick 23, JH Soslow 24, J Steele 25, KW Stern 26, B Thattaliyath 27, A Vaikom House 28, J Weigand 29
1 Department of Pediatrics, St. Louis Children's Hospital, St. Louis, MO 
2 The Heart and Vascular Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 
3 Congenital Heart Center, CS Mott Children's Hospital, Ann Arbor, MI 
4 Department of Pediatric and Congenital Cardiology, John Hopkins Hospital, Baltimore, MD 
5 Division of Pediatric Cardiology, Seattle Children’s Hospital, Seattle, WA 
6 Division of Cardiology, The Children's Hospital of Philadelphia, Pennsylvania, PA 
7 Division of Pediatric Cardiology, Rady Children's Hospital, San Diego, CA 
8 Division of Pediatric Cardiology, University of Arizona, Tucson, AZ 
9 Division of Pediatric Cardiology, Riley Hospital for Children, Indianapolis, IN 
10 Department of Radiology, Nationwide Children's Hospital, Columbus, OH 
11 Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, Canada 
12 Division of Cardiology, Children's National Hospital, Washington DC 
13 Department of Bioengineering & Pediatrics, Stanford University, Palo Alto, CA 
14 UCL Centre for Cardiovascular Imaging, Institute of Cardiovascular Science, London, UK 
15 Congenital Cardiology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy 
16 Division of Pediatric Cardiology, University of Kentucky, Lexington, KY 
17 Department of Cardiology, Boston Children’s Hospital, Boston, MA 
18 Division of Pediatric Cardiology, CHOC Children’s Hospital, Orange, CA 
19 Division of Pediatric Cardiology, Arkansas Children's Hospital, Little Rock, AR 
20 Division of Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL 
21 Division of Pediatric Cardiology, Cedars-Sinai Guerin Children's Hospital, Los Angeles, CA 
22 Division of Pediatric Cardiology, New York-Presbyterian Morgan Stanley Children’s Hospital, New York, NY 
23 Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Atlanta, GA 
24 Division of Pediatric Cardiology, Vanderbilt University Medical Center, Nashville, TN 
25 Division of Pediatric Cardiology, Yale New Haven Children's Hospital, New Haven, CT 
26 Division of Pediatric Cardiology, Mount Sinai Kravis Children's Hospital, New York, NY 
27 Division of Pediatric Cardiology, Stead Family Children's Hospital, Iowa City, IA 
28 Division of Pediatric Cardiology, Oklahoma Children's Hospital, Oklahoma City, OK 
29 Division of Pediatric Cardiology, Texas Children's Hospital, Houston, TX 

a Heart Institute, UPMC Children’s Hospital of Pittsburgh, Department of Pediatrics, Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 
b Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 
c Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA 
d Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 
e Division of Pediatric Cardiology, George Washington University School of Medicine & Health Sciences, Washington, DC 
f Division of Cardiology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 
g Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 
h Department of Radiology, Nationwide Children’s Hospital, Columbus, OH 
i UCL Centre for Cardiovascular Imaging, Institute of Cardiovascular Science, University College London, London, UK 
j Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 
k Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, and Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada 
l Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 
m Department of Pediatrics, Ann & Robert H. Lurie’s Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 
n Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 

Reprint requests: Tarek Alsaied, MD, MSc, Heart Institute, UPMC Children's Hospital of Pittsburgh, Department of Pediatrics, Division of Cardiology, University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA 15224.Heart Institute, UPMC Children's Hospital of Pittsburgh, Department of Pediatrics, Division of CardiologyUniversity of Pittsburgh School of Medicine4401 Penn AvenuePittsburghPA15224

ABSTRACT

Background

Following the Fontan procedure, patients with single ventricle physiology are at high risk of diastolic dysfunction (DD) and elevated end-diastolic pressure (EDP).

Objective

This study aims to determine (1) the optimal EDP threshold correlated with adverse outcomes post-Fontan and (2) the clinical and imaging predictors of DD.

Methods

The study included patients from the Fontan Outcome Registry using CMR Examinations (FORCE) who underwent cardiac catheterization and cardiac magnetic resonance (CMR) within a 2-year window. The composite outcome was defined as all-cause mortality, sustained atrial or ventricular arrhythmia, plastic bronchitis, protein-losing enteropathy, or listing for transplantation. The EDP cutoff was determined using the lowest Brier score from Cox proportional hazard models.

Results

The study included 861 patients (mean age 16.4 ± 9.3 years). Mean EDP was 9.0 ± 3.5 mm Hg, with DD defined at an optimal EDP threshold >13 mm Hg. Patients were followed for a median of 3.6 years after catheterization. By univariable analysis patients with DD were more likely to have Fontan associated liver disease (40% vs 29%, P = .03) and kidney disease (19% vs 6%, P < .001). In multivariable analyses, DD was associated with the composite outcome (HR 3.37, 95% CI: 2.03-5.59, P < .001). Ninety-seven patients (11.3%) had DD. Multivariable analysis demonstrated that older age at catheterization, greater body mass index (BMI), nonleft ventricular morphology, and higher ventricular end-diastolic volume (EDV) were associated with DD.

Conclusion

DD, defined as an EDP >13 mm Hg, is linked to over 3-fold higher risk of adverse outcomes. Risk factors for DD include older age, higher BMI, nonleft ventricular morphology, and larger EDV. The presence of risk factors may warrant screening catheterization to identify DD and modify care accordingly.

El texto completo de este artículo está disponible en PDF.

Abbreviations : AVVR, DD, EDP, PLE, ICD, FORCE, CMR, NYHA, LGE, EDV


Esquema


© 2025  The Author(s). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 290

P. 288-296 - décembre 2025 Regresar al número
Artículo precedente Artículo precedente
  • Incremental cost of complications after TAVR and SAVR in contemporary clinical practice
  • James E. Harvey, Michael Ryan, Candace Gunnarsson, Soumya Chikermane, Suzanne J. Baron
| Artículo siguiente Artículo siguiente
  • Referral patterns and clinical outcomes in patients with severe aortic stenosis: A multicenter cohort study
  • Azin Vakilpour, Michael G Levin, Emeka C Anyanwu, Srinivas Denduluri, Krishna Ravindra, Ellen Boakye, Estherland Duqueney, Jamey A Cutts, Liam C Giffin, Ian K Weber, Jennifer N. Lee, Srinath Adusumalli, Juan Lopez-Mattei, Jesse Chittams, David B. Jones, Kathleen Weiss, Carlton Hartwell, Michael Bolooki, Jamieson M Bourque, Marielle Scherrer-Crosbie

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.